Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$50.3M
-1.8% from 2023
Prescriptions
4,120
$12,206.21 per claim
Patients
690
383 prescribers
Total spending, 2024
$50.3M
$72,883.44 per patient
Medicare prescription drug plans paid $50.3M for Opdivo in 2024, for 4,120 prescriptions and refills to 690 patients (down 1.8% from 2023). The average cost per claim was $12,206.21.
California had the highest Medicare cost for Opdivo in 2024: $10.8M for 888 claims, followed by New York ($7.2M).
Nader Javadi, hematology-oncology in Calabasas, CA, had the highest Medicare cost for Opdivo in 2024: 127 claims costing $1.5M.
Opdivo is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as BMS Primarycare.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Nader Javadi Calabasas, CA | Hematology-Oncology | 127 | 24 | $1.5M |
| Asit J Choksi The Woodlands, TX | Hematology-Oncology | 114 | 13 | $1.3M |
| Swetha S Yadav |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 324 | 3,605 | 616 | $43.8M |
| 2023 | 350 | 4,001 | 693 | $51.2M |
| 2024 | 383 | 4,120 | 690 | $50.3M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 72 |
| 11 |
| $986K |
| Syed S Rafique Greenwood, MS | Hematology-Oncology | 66 | Under 11 | $945K |
| Norland Ng New York, NY | Hematology-Oncology | 60 | Under 11 | $924K |
| Rohit Kapoor Live Oak, TX | Hematology-Oncology | 59 | Under 11 | $813K |
| Aasim S Sehbai Anniston, AL | Medical Oncology | 58 | Under 11 | $787K |
| Songchuan Guo Brooklyn, NY | Hematology-Oncology | 70 | 15 | $735K |
| Azriel Hirschfeld Brooklyn, NY | Hematology-Oncology | 47 | 13 | $692K |
| David P Ellent Kingwood, TX | Hematology-Oncology | 45 | Under 11 | $679K |
| Ghassan Al-Jazayrly Los Angeles, CA | Hematology-Oncology | 88 | 12 | $631K |
| Maria A Scouros Houston, TX | Hematology-Oncology | 44 | Under 11 | $610K |
| William Cheung New York, NY | Internal Medicine | 44 | Under 11 | $602K |
| Tarek I Hassanein Coronado, CA | Gastroenterology | 39 | Under 11 | $589K |
| Anil V Tumkur Greeneville, TN | Hematology-Oncology | 45 | Under 11 | $528K |
| Said Saleh Belleville, NJ | Hematology-Oncology | 33 | Under 11 | $516K |
| Kirtan N Koticha Shreveport, LA | Hematology-Oncology | 44 | Under 11 | $515K |
| Jolly Varki Miami, FL | Hematology-Oncology | 30 | Under 11 | $456K |
| Amir A Rasheed Baytown, TX | Hematology-Oncology | 41 | Under 11 | $432K |
| Arindam Bagchi Columbia, MO | Hematology-Oncology | 29 | Under 11 | $420K |
| Joseph My Stuart, FL | Hematology-Oncology | 28 | Under 11 | $414K |
| Prashant R Patel Stuart, FL | Hematology-Oncology | 40 | Under 11 | $413K |
| Deanna Oliver San Diego, CA | Internal Medicine | 26 | Under 11 | $390K |
| Christopher S Ho West Hills, CA | Hematology-Oncology | 25 | Under 11 | $388K |
| Antoine E Chahine Canfield, OH | Medical Oncology | 51 | Under 11 | $388K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| BMS Primarycare BMY | 4,120 | $50.3M |